To make the most impact, we are focused on a few select research areas that hold the most promise for advancing the field of immunotherapy and helping patients. We bring together the world’s top scientists in academia and industry to tackle major questions in these key areas:
Advance the next generation of T-cell therapies to provide targeted, safe, long-lasting treatments that can conquer cancer.
Uncover the reasons why some patients respond to immunotherapy while others may not, in order to overcome cancer drug resistance.
Pinpoint novel cancer cell markers that will become the foundation for new therapies and personalized treatments.
Discover how tumors impair immune cells, which will jumpstart the creation of therapies that can fight hard-to-treat solid tumors.
Our investigators collaborate on high-risk, high-reward research projects.